Three-Dimensional In Vitro Co-Culture Model of Breast Tumor using Magnetic Levitation

被引:176
作者
Jaganathan, Hamsa [1 ]
Gage, Jacob [2 ]
Leonard, Fransisca [1 ]
Srinivasan, Srimeenakshi [1 ]
Souza, Glauco R. [2 ]
Dave, Bhuvanesh [3 ]
Godin, Biana [1 ]
机构
[1] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA
[2] n3D Biosiences Inc, Houston, TX 77030 USA
[3] Houston Methodist Res Inst, Canc Ctr Excellence, Houston, TX 77030 USA
来源
SCIENTIFIC REPORTS | 2014年 / 4卷
基金
美国国家科学基金会;
关键词
STROMA RATIO; PROGNOSTIC-SIGNIFICANCE; CANCER PATIENTS; CULTURE; TISSUE; CELLS; VALIDATION; MATRIX;
D O I
10.1038/srep06468
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this study, we investigate a novel in vitro model to mimic heterogeneous breast tumors without the use of a scaffold while allowing for cell-cell and tumor-fibroblast interactions. Previous studies have shown that magnetic levitation system under conventional culturing conditions results in the formation of three-dimensional (3D) structures, closely resembling in vivo tissues (fat tissue, vasculature, etc.). Three-dimensional heterogeneous tumor models for breast cancer were designed to effectively model the influences of the tumor microenvironment on drug efficiency. Various breast cancer cells were co-cultured with fibroblasts and then magnetically levitated. Size and cell density of the resulting tumors were measured. The model was phenotypically compared to in vivo tumors and examined for the presence of ECM proteins. Lastly, the effects of tumor stroma in the 3D in vitro model on drug transport and efficiency were assessed. Our data suggest that the proposed 3D in vitro breast tumor is advantageous due to the ability to: (1) form large-sized (millimeter in diameter) breast tumor models within 24 h; (2) control tumor cell composition and density; (3) accurately mimic the in vivo tumor microenvironment; and (4) test drug efficiency in an in vitro model that is comparable to in vivo tumors.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
    Bauer, Joshua A.
    Ye, Fei
    Marshall, Clayton B.
    Lehmann, Brian D.
    Pendleton, Christopher S.
    Shyr, Yu
    Arteaga, Carlos L.
    Pietenpol, Jennifer A.
    [J]. BREAST CANCER RESEARCH, 2010, 12 (03):
  • [2] 3D culture of adult mouse neural stem cells within functionalized self-assembling peptide scaffolds
    Cunha, Carla
    Panseri, Silvia
    Villa, Omar
    Silva, Diego
    Gelain, Fabrizio
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 : 943 - 955
  • [3] Daquinag AC, 2013, TISSUE ENG PART C-ME, V19, P336, DOI [10.1089/ten.tec.2012.0198, 10.1089/ten.TEC.2012.0198]
  • [4] Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
    Dave, Bhuvanesh
    Granados-Principal, Sergio
    Zhu, Rui
    Benz, Stephen
    Rabizadeh, Shahrooz
    Soon-Shiong, Patrick
    Yu, Ke-Da
    Shao, Zhimin
    Li, Xiaoxian
    Gilcrease, Michael
    Lai, Zhao
    Cheng, Yidong
    Huang, Tim H. -M.
    Shen, Haifa
    Liu, Xuewu
    Ferrari, Mauro
    Zhan, Ming
    Wong, Stephen T. C.
    Kumaraswami, Muthiah
    Mittal, Vivek
    Chen, Xi
    Gross, Steven S.
    Chang, Jenny C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (24) : 8838 - 8843
  • [5] Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
    de Kruijf, Esther M.
    van Nes, Johanna G. H.
    de Velde, Cornelis J. H. van
    Putter, Hein
    Smit, Vincent T. H. B. M.
    Liefers, Gerrit Jan
    Kuppen, Peter J. K.
    Tollenaar, Rob A. E. M.
    Mesker, Wilma E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) : 687 - 696
  • [6] Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
    Dekker, T. J. A.
    van de Velde, C. J. H.
    van Pelt, G. W.
    Kroep, J. R.
    Julien, J-P.
    Smit, V. T. H. B. M.
    Tollenaar, R. A. E. M.
    Mesker, W. E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 371 - 379
  • [7] The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
    Downey, C. L.
    Simpkins, S. A.
    White, J.
    Holliday, D. L.
    Jones, J. L.
    Jordan, L. B.
    Kulka, J.
    Pollock, S.
    Rajan, S. S.
    Thygesen, H. H.
    Hanby, A. M.
    Speirs, V.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (07) : 1744 - 1747
  • [8] Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib
    Grantab, Rama H.
    Tannock, Ian F.
    [J]. BMC CANCER, 2012, 12
  • [9] Three-dimensional cell culturing by magnetic levitation
    Haisler, William L.
    Timm, David M.
    Gage, Jacob A.
    Tseng, Hubert
    Killian, T. C.
    Souza, Glauco R.
    [J]. NATURE PROTOCOLS, 2013, 8 (10) : 1940 - 1949
  • [10] Three-dimensional in vitro tissue culture models of breast cancer -: a review
    Kim, JB
    Stein, R
    O'Hare, MJ
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (03) : 281 - 291